Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis

Neurology

Volumn 82, Issue 7, 2014, Pages 556-563

  Viaccoz, Aurélien ^a,b,c   Desestret, Virginie ^b,c   Ducray, François ^a,b,c   Picard, Géraldine ^a   Cavillon, Gaëlle ^a   Rogemond, Véronique ^a   Antoine, Jean Christophe ^a,b,e   Delattre, Jean Yves ^a,d   Honnorat, Jérôme ^a,b,c  

^a HÔPITAL NEUROLOGIQUE   (France)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB;

ADULT; AGED; AGITATION; ANTEROGRADE AMNESIA; ARTICLE; ATTENTION DEFICIT DISORDER; CD4 LYMPHOCYTE COUNT; CEREBELLUM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COHORT ANALYSIS; CONFUSION; DISORIENTATION; DYSAUTONOMIA; ENCEPHALITIS; FEMALE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HEMIANOPIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPERSEXUALITY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOTOR DYSFUNCTION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; OBSERVATIONAL STUDY; OVARY TERATOMA; PRIORITY JOURNAL; PSYCHOSIS; PYREXIA IDIOPATHICA; RESPIRATORY TRACT INFECTION; SEIZURE; SPEECH DISORDER; TONIC CLONIC SEIZURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PRODROMAL SYMPTOMS; SEIZURES; SEX FACTORS; YOUNG ADULT;

EID: 84895744753     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000126     Document Type: Article

References (40)

1. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-Nmethyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
2. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866-5875.
3. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012;135:1606-1621.
4. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157-165.
5. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
6. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655-1667.
7. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
8. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28:1421-1429.
9. Sakamoto H, Hirano M, Samukawa M, et al. Details of treatment-related difficulties in men with anti-N-methyl-Daspartate receptor encephalitis. Eur Neurol 2012;69:21-26.
10. Tsutsui K, Kanbayashi T, Tanaka K, et al. Anti-NMDAreceptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 2012;12:37.
11. Kung DH, Qiu C, Kass JS. Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor. Psychosomatics 2011;52:82-85.
12. Braakman HM, Moers-Hornikx VM, Arts BM, Hupperts RM, Nicolai J. Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010;75:e44-e46.
13. Eker A, Saka E, Dalmau J, et al. Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 2008;79:1082-1083.
14. Matsumoto T, Matsumoto K, Kobayashi T, Kato S. Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis. Psychiatry Clin Neurosci 2012;66:242-243.
15. Wilder-Smith EP, Ng ES. The writing on the wall. Lancet 2008;372:344.
16. Kubota A, Tajima T, Narukawa S, et al. Anti-Ma2, anti-NMDA-receptor and anti-GluRepsilon2 limbic encephalitis with testicular seminoma: short-term memory disturbance [in Japanese]. Rinsho Shinkeigaku 2012;52:666-671.
17. Frechette ES, Zhou L, Galetta SL, Chen L, Dalmau J. Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology 2011; 76:S64-S66.
18. Kitada M, Suzuki H, Ichihashi J, Mitsui Y, Tanaka K, Kusunoki S. Dramatic improvement in two cases of anti-NMDA receptor encephalitis after immunomodulating therapy [in Japanese]. Rinsho Shinkeigaku 2011;51: 683-687.
19. Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology 2009;73:2039-2040.
20. Novillo-Lopez ME, Rossi JE, Dalmau J, Masjuan J. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology 2008; 70:728-729.
21. Finke C, Kopp UA, Pruss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2012;83: 195-198.
22. Day GS, High SM, Cot B, Tang-Wai DF. Anti-NMDAreceptor encephalitis: case report and literature review of an under-recognized condition. J Gen Intern Med 2011; 26:811-816.
23. Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011;77:439-443.
24. GhilusiM, Plesea IE, Comanescu M, Enache SD, Bogdan F. Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas. Rom J Morphol Embryol 2009;50:195-202.
25. Tuzun E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009;118:737-743.
26. Dabner M, McCluggage WG, Bundell C, et al. Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 2012;31:429-437.
27. Sammaritano LR. Menopause in patients with autoimmune diseases. Autoimmun Rev 2012;11:A430-A436.
28. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptordependent mechanism. J Neurosci 1994;14:7680-7687.
29. Lynch JJ 3rd, Shek EW, Castagne V, Mittelstadt SW. The proconvulsant effects of leptin on glutamate receptormediated seizures in mice. Brain Res Bull 2010;82:99-103.
30. Pennell PB. Hormonal aspects of epilepsy. Neurol Clin 2009;27:941-965.
31. Wang J, Wang J, Zhang Y, et al. Proteomic analysis of adrenocorticotropic hormone treatment of an infantile spasm model induced by N-methyl-D-aspartic acid and prenatal stress. PLoS One 2012;7:e45347.
32. Kalkbrenner KA, Standley CA. Estrogen modulation of NMDA-induced seizures in ovariectomized and nonovariectomized rats. Brain Res 2003;964:244-249.
33. Scharfman HE, MacLusky NJ. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 2006;47:1423-1440.
34. Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009;6: 392-401.
35. Smith SS. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res 1989;503:354-357.
36. Wong M, Moss RL. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 1992;12:3217-3225.
37. Klein P, Herzog AG. Hormonal effects on epilepsy in women. Epilepsia 1998;39(suppl 8):S9-S16.
38. Pouliot WA, Handa RJ, Beck SG. Androgen modulates N-methyl-D-aspartate- mediated depolarization in CA1 hippocampal pyramidal cells. Synapse 1996;23:10-19.
39. Rhodes ME, Frye CA. Androgens in the hippocampus can alter, and be altered by, ictal activity. Pharmacol Biochem Behav 2004;78:483-493.
40. Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D- aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013;162:850-856.e2.